What is the recommended azithromycin regimen for uncomplicated Shigella infection in adults and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Azithromycin for Shigella Infection

Azithromycin is a highly effective first-line treatment for shigellosis, with a recommended regimen of 500 mg on day 1 followed by 250 mg daily for days 2-5 in adults, or 10 mg/kg (max 500 mg) on day 1 followed by 5 mg/kg daily (max 250 mg) on days 2-5 in children. 1, 2

Rationale for Azithromycin as First-Line

The most recent WHO guidelines (2024) explicitly recommend azithromycin as an alternative oral choice for shigellosis, particularly in regions with high fluoroquinolone resistance 1. This represents a significant shift from older recommendations that prioritized ciprofloxacin, driven by:

  • Rising fluoroquinolone resistance: Resistance rates to nalidixic acid and ciprofloxacin have progressively increased, particularly in Asia-Africa where rates reached 33.6% and 5.0% respectively 1
  • Proven efficacy: Azithromycin demonstrates 82-94% clinical success rates and 94-100% bacteriologic eradication in shigellosis 3, 4, 5
  • Strong guideline support: The 2017 travelers' diarrhea guidelines give azithromycin a "strong recommendation, high level of evidence" for dysentery treatment 2

Specific Dosing Regimens

Adults

  • Standard 5-day course: 500 mg on day 1, then 250 mg daily on days 2-5 1, 2
  • Alternative single-dose: 1 gram as a single dose (though 5-day course preferred for shigellosis) 2

Children

  • 5-day course: 10 mg/kg (maximum 500 mg) on day 1, followed by 5 mg/kg daily (maximum 250 mg) on days 2-5 1, 6
  • Alternative 3-day course: 10 mg/kg daily for 3 days 4, 5

Infants <6 months

  • 10 mg/kg per day for 5 days 6

When to Use Azithromycin vs. Ciprofloxacin

Choose azithromycin preferentially when:

  • Treating dysentery (bloody diarrhea with fever, abdominal cramps, tenesmus) 2
  • Patient has traveled to areas with known fluoroquinolone resistance (Southeast Asia, India, sub-Saharan Africa) 2
  • Treating children (avoids arthropathy concerns with fluoroquinolones) 1
  • Local resistance patterns show >10% ciprofloxacin resistance 1

Ciprofloxacin (15 mg/kg or 500 mg twice daily for 3 days) remains acceptable when:

  • Local susceptibility patterns confirm low fluoroquinolone resistance 1
  • Azithromycin is unavailable 1
  • However, note that ciprofloxacin is no longer first-line due to widespread resistance 2

Alternative Second-Line Options

If azithromycin fails or is contraindicated:

  • Cefixime: Effective oral cephalosporin option 1
  • Ceftriaxone: Parenteral option for severe cases (resistance rates 2.5% in Asia-Africa) 1, 4, 5

Critical Caveats

Emerging azithromycin resistance: Recent outbreak data shows treatment failures with azithromycin when isolates contain mph(A) and erm(B) resistance genes with MICs >16 µg/mL 7. In one Vermont outbreak, all 4 patients treated with azithromycin experienced clinical failure 7. This underscores the importance of:

  • Obtaining stool cultures when possible
  • Monitoring clinical response at 48-72 hours
  • Switching antibiotics if no improvement occurs 8

Do not use for asymptomatic carriers: Mass prophylaxis is not recommended 8. Treat only symptomatic patients with confirmed or highly suspected shigellosis.

Avoid older agents: Ampicillin and trimethoprim-sulfamethoxazole show 37% combined resistance rates in the US and should not be used empirically 9, 10.

Expected Clinical Response

  • Clinical improvement: Should occur within 48-72 hours 8
  • Bacteriologic clearance: Typically by day 3-5 3, 11
  • If no response by day 2: Switch to alternative antibiotic based on susceptibility testing 8

References

Research

Antimicrobial treatment of diarrhea/acute gastroenteritis in children.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2017

Research

Azithromycin and Ciprofloxacin Treatment Outcomes During an Outbreak of Multidrug-Resistant Shigella sonnei Infections in a Retirement Community-Vermont, 2018.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022

Research

Options for treating resistant Shigella species infections in children.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.